BeOne Medicines has secured approval from the European Commission (EC) for Tevimbra (tislelizumab) to be used along with ...

Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of your throat, behind the nose. This area is called the nasopharynx. The nasopharynx is precariously ...

Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in ...

Distinct tumor immune microenvironments (TIME) characterize subtypes of locoregionally advanced nasopharyngeal carcinoma, influencing disease progression and treatment response.

Nasopharyngeal cancer is when abnormal cells in the nasopharynx start to divide and grow in an uncontrolled way. The cells can grow into surrounding tissues or organs and may spread to other areas of ...

A new study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the ...

“Throat cancer” can actually mean more than one kind of cancer, and each affects a different place in your throat. Learn about the different types, the signs of each one, and how each is treated.

Source Reference: Castle PE, Han PKJ "On the nose: reducing nasopharyngeal cancer-related mortality using risk-based Epstein-Barr virus serology screening" J Clin Oncol 2024; DOI: 10.1200/JCO.23. ...

Researchers conducted the randomized phase 3 DIPPER trial at 11 centers in China, enrolling 450 patients with T4N1M0 or T1-4N2-3M0 nasopharyngeal carcinoma who had completed induction-concurrent ...

The precise origin of nasopharyngeal cancer remains unclear, but researchers have identified several contributing factors. One of the primary nasopharyngeal cancer causes is infection with the ...

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. P Bossi and others. Annals of Oncology, 2021. Volume 32, Issue 4, Pages 452-465.